Active

Sofinnova Partners

Investor type

VC

Founded

1972

AUM

$4 320 M

Location

Paris, Île-de-France, France

Investment Ticket

$10-50 m

Investment Stage

Late Stage (Series C+) Series B Series A Seed

Region of investment

North America Europe

ESG Focus

Impact investor
Investor profile last updated: 27 August, 2026

Profile

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com

Industry

Life Sciences MedTech Medical Devices Industrial Healthcare Services Food and Beverage Digital Biotechnology Agriculture ClimateTech AgriTech HealthTech SaaS Software Energy Foodtech

Sofinnova Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Sofinnova Biovelocita II
Venture Capital (VC)
Biotechnology
Healthcare Services
Pre-seed
Seed
Europe
$5-10 m
$181 M
March 2025
Life Science
Venture Capital (VC)
MedTech
Pre-seed
Seed
Europe
$5-10 m
$1296 M
March 2025
Sofinnova Digital Medicine I
Venture Capital (VC)
Biotechnology
Digital
Healthcare Services
Pre-seed
Seed
Europe
$5-10 m
$200 M
October 2023
Sofinnova Capital XI
Venture Capital (VC)
Healthcare Services
SaaS
Software
Life Sciences
Energy
HealthTech
Seed
North America
Europe
$5-10 m
$750 M
November 2025
Sofinnova Biovelocita II
Venture Capital (VC)
Food and Beverage
Foodtech
Healthcare Services
Life Sciences
Energy
HealthTech
Seed
North America
Europe
$5-10 m
$170 M
March 2025

Contacts

Name
Title
Email
avatar
Antoine Papiernik Chairman & Managing Partner, Sofinnova Partners
Chairman & Managing Partner, Sofinnova Partners
a•••@•••
avatar
Henrijette Richter Managing Partner, Sofinnova Partners
Managing Partner, Sofinnova Partners
h•••@•••
Upgrade to see contacts
avatar
nziBevYa9QPO1XqS nziBevYa9QPO1XqS
nziBevYa9QPO1XqS
avatar
nziBevYa9QPO1XqS nziBevYa9QPO1XqS
nziBevYa9QPO1XqS
avatar
nziBevYa9QPO1XqS nziBevYa9QPO1XqS
nziBevYa9QPO1XqS
Investment-team contacts for Sofinnova Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Sofinnova Partners

Sofinnova Partners is a venture capital firm. It backs companies at Late Stage (Series C+), Series B, Series A and Seed, writing tickets of $10-50 m.
Sofinnova Partners is located in Paris, Île-de-France, France.
Sofinnova Partners was founded in 1972.
Sofinnova Partners invests in companies and startups in Life Sciences, MedTech, Medical Devices, Industrial, Healthcare Services, Food and Beverage, Digital, Biotechnology, Agriculture, ClimateTech, AgriTech, HealthTech, SaaS, Software, Energy, Foodtech.
Sofinnova Partners invests in companies and startups in North America, Europe.
Sofinnova Partners invests in companies and startups at Late Stage (Series C+), Series B, Series A, Seed.
Sofinnova Partners usually invests $10-50 m on average.
Sofinnova Partners has around $4 320m assets under management.
Sofinnova Partners last fund was created/launched in 2025-11-17
Yes, Sofinnova Partners is impact investor.
Sofinnova Partners can be reached through its website sofinnovapartners.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Sofinnova Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Sofinnova Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 27 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.